| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J Levin. Controlled trials of inositol in psychiatry. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 7. issue 2. 1997-07-21. PMID:9169302. |
these results suggest that inositol has therapeutic effects in the spectrum of illness responsive to serotonin selective re-uptake inhibitors, including depression, panic and ocd, and is not beneficial in schizophrenia, alzheimer's addh, autism or ect-induced cognitive impairment. |
1997-07-21 |
2023-08-12 |
Not clear |
| J Hérault, E Petit, J Martineau, C Cherpi, A Perrot, C Barthélémy, G Lelord, J P Mü. Serotonin and autism: biochemical and molecular biology features. Psychiatry research. vol 65. issue 1. 1997-03-12. PMID:8953659. |
serotonin and autism: biochemical and molecular biology features. |
1997-03-12 |
2023-08-12 |
human |
| J Hérault, E Petit, J Martineau, C Cherpi, A Perrot, C Barthélémy, G Lelord, J P Mü. Serotonin and autism: biochemical and molecular biology features. Psychiatry research. vol 65. issue 1. 1997-03-12. PMID:8953659. |
significant group (high urinary 5-ht and low whole blood 5-ht in autism) and age effects (urinary 5-ht decrease with age) were found. |
1997-03-12 |
2023-08-12 |
human |
| E H Cook, B L Leventha. The serotonin system in autism. Current opinion in pediatrics. vol 8. issue 4. 1997-03-07. PMID:9053096. |
the serotonin system has been implicated as a factor in some cases of autism since the finding in 1961 of elevated serotonin (5-hydroxytryptamine) levels in the blood of patients with autism. |
1997-03-07 |
2023-08-12 |
human |
| E H Cook, B L Leventha. The serotonin system in autism. Current opinion in pediatrics. vol 8. issue 4. 1997-03-07. PMID:9053096. |
most individuals with autism who are treated with potent serotonin transporter inhibitors have a reduction in ritualistic behavior and aggression. |
1997-03-07 |
2023-08-12 |
human |
| R P Warren, V K Sing. Elevated serotonin levels in autism: association with the major histocompatibility complex. Neuropsychobiology. vol 34. issue 2. 1997-02-12. PMID:8904735. |
elevated serotonin levels in autism: association with the major histocompatibility complex. |
1997-02-12 |
2023-08-12 |
human |
| R P Warren, V K Sing. Elevated serotonin levels in autism: association with the major histocompatibility complex. Neuropsychobiology. vol 34. issue 2. 1997-02-12. PMID:8904735. |
two of the most consistently observed biological findings in autism are increased serotonin levels in the blood and immunological abnormalities (including autoreactivity with tissues of the central nervous system). |
1997-02-12 |
2023-08-12 |
human |
| R P Warren, V K Sing. Elevated serotonin levels in autism: association with the major histocompatibility complex. Neuropsychobiology. vol 34. issue 2. 1997-02-12. PMID:8904735. |
since the mhc is known to regulate the immune system and is also associated with autoimmune disorders, we studied serum serotonin levels in 20 autistic subjects with or without mhc types previously found to be associated with autism. |
1997-02-12 |
2023-08-12 |
human |
| R P Warren, V K Sing. Elevated serotonin levels in autism: association with the major histocompatibility complex. Neuropsychobiology. vol 34. issue 2. 1997-02-12. PMID:8904735. |
a positive relationship was observed between elevated serotonin levels and the mhc types previously associated with autism. |
1997-02-12 |
2023-08-12 |
human |
| C J McDougle, S T Naylor, D J Cohen, F R Volkmar, G R Heninger, L H Pric. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of general psychiatry. vol 53. issue 11. 1996-12-06. PMID:8911223. |
abnormalities in the serotonin neurotransmitter system have been identified in some persons with autism. |
1996-12-06 |
2023-08-12 |
Not clear |
| R J Harvey, S E Coora. The effective treatment of severe repetitive behaviour with fluvoxamine in a 20 year old autistic female. International clinical psychopharmacology. vol 10. issue 3. 1996-08-13. PMID:8675975. |
the connection between repetitive symptoms in autism and obsessive-compulsive disorder is considered, and the need for further evaluation of selective serotonin reuptake inhibitors in autism is discussed. |
1996-08-13 |
2023-08-12 |
Not clear |
| N Taked. Serotonin-degradative pathways in the toad (Bufo bufo japonicus) brain: clues to the pharmacological analysis of human psychiatric disorders. Comparative biochemistry and physiology. Pharmacology, toxicology and endocrinology. vol 107. issue 2. 1995-06-16. PMID:7749594. |
it appears, therefore, that some aspects of the central nervous system of bufo may provide useful pharmacological clues to the etiology of human psychiatric diseases, such as autism, that are known to be linked to the methylation of serotonin. |
1995-06-16 |
2023-08-12 |
human |
| S Dollfus, M Petit, J M Launay, J Callebert, P Boudou, C Dreux, J F Ménar. [Platelet serotonin in infantile autism. Cross-over effects of a dopamine agonist and an antagonist]. L'Encephale. vol 18. issue 6. 1994-02-17. PMID:1364154. |
[platelet serotonin in infantile autism. |
1994-02-17 |
2023-08-11 |
Not clear |
| S Dollfus, M Petit, J M Launay, J Callebert, P Boudou, C Dreux, J F Ménar. [Platelet serotonin in infantile autism. Cross-over effects of a dopamine agonist and an antagonist]. L'Encephale. vol 18. issue 6. 1994-02-17. PMID:1364154. |
in infantile autism, the serotoninergic (5-ht) hypothesis is corroborated by biological dosages and therapeutic effects of fenfluramine which decrease blood serotonin. |
1994-02-17 |
2023-08-11 |
Not clear |
| S Dollfus, M Petit, J M Launay, J Callebert, P Boudou, C Dreux, J F Ménar. [Platelet serotonin in infantile autism. Cross-over effects of a dopamine agonist and an antagonist]. L'Encephale. vol 18. issue 6. 1994-02-17. PMID:1364154. |
we evaluated in a randomized, double-blind and cross-over study, the effects of a da agonist (bromocriptine) and a da antagonist (amisulpride) on platelet 5-ht in infantile autism. |
1994-02-17 |
2023-08-11 |
Not clear |
| M G Naffah-Mazzacoratti, R Rosenberg, M J Fernandes, C M Draque, W Silvestrini, L Calderazzo, E A Cavalheir. Serum serotonin levels of normal and autistic children. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 26. issue 3. 1994-01-19. PMID:8257930. |
the method employed in this study showed high resolution, good sensitivity and can be used for routine determination of serum 5ht in the clinical investigation of hyperserotonemia in autism. |
1994-01-19 |
2023-08-12 |
Not clear |
| E H Cook, R C Arora, G M Anderson, E M Berry-Kravis, S Y Yan, H C Yeoh, P J Sklena, D A Charak, B L Leventha. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life sciences. vol 52. issue 25. 1993-07-01. PMID:7684805. |
hyperserotonemia of autism may be heterogeneous with one subgroup of subjects with increased 5-ht uptake and another subgroup with decreased 5-ht2 binding. |
1993-07-01 |
2023-08-12 |
human |
| J Martineau, C Barthélémy, J Jouve, J P Muh, G Lelor. Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects. Developmental medicine and child neurology. vol 34. issue 7. 1992-10-01. PMID:1380929. |
monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects. |
1992-10-01 |
2023-08-11 |
Not clear |
| A Yuwiler, J C Shih, C H Chen, E R Ritvo, G Hanna, G W Ellison, B H Kin. Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. Journal of autism and developmental disorders. vol 22. issue 1. 1992-07-01. PMID:1375597. |
this study examined the linkage between elevated blood serotonin in autism and the presence of circulating autoantibodies against the serotonin 5ht1a receptor. |
1992-07-01 |
2023-08-11 |
human |
| A Yuwiler, J C Shih, C H Chen, E R Ritvo, G Hanna, G W Ellison, B H Kin. Hyperserotoninemia and antiserotonin antibodies in autism and other disorders. Journal of autism and developmental disorders. vol 22. issue 1. 1992-07-01. PMID:1375597. |
blood serotonin was measured as was inhibition of serotonin binding to human cortical membranes by antibody-rich fractions of blood from controls and from patients with childhood autism, schizophrenia, obsessive-compulsive disorder, tourette's, and multiple sclerosis. |
1992-07-01 |
2023-08-11 |
human |